Does Infinity Pharmaceuticals Inc. (INFI)s Current Price Volatility Hinder Its Future Potential?
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) has a beta value of 2.21 and has seen 0.76 million shares traded in the recent trading session. The company, currently valued at $304.08M, closed the recent trade at $3.39 per share which meant it lost -$0.06 on the day or -1.80% during that session. The INFI stock price is -76.4% off its 52-week high price of $5.98 and 76.99% above the 52-week low of $0.78. If we look at the companys 10-day average daily trading volume, we find that it stood at 1.46 million shares traded. The 3-month trading volume is 1.56 million shares. The consensus among analysts is that Infinity Pharmaceuticals Inc. (INFI) is an Overweight stock at the moment, with a recommendation rating of 2.10. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 2 out of 7 have rated it as a Hold, with 5 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.14. Infinity Pharmaceuticals Inc. (NASDAQ:INFI) trade information  Sporting -1.80% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Friday, 06/11/21 when the INFI stock price touched $3.39 or saw a rise of 8.87%. Year-to-date, Infinity Pharmaceuticals Inc. shares have moved 62.74%, while the 5-day performance has seen it change 4.55%. Over the past 30 days, the shares of Infinity Pharmaceuticals Inc. (NASDAQ:INFI) have changed 22.34%. Short interest in the company has seen 3.9 million shares shorted with days to cover at 2.71. Wall Street analysts have a consensus price target for the stock at $8.50, which means that the shares value could jump 60.12% from the levels at last check today. The projected low price target is $4.00 while the price target rests at a high of $12.00. In that case, then, we find that the latest price level in todays session is -253.98% off the targeted high while a plunge would see the stock gain -17.99% from the levels at last check today. Infinity Pharmaceuticals Inc. (INFI) estimates and forecasts  Figures show that Infinity Pharmaceuticals Inc. shares have underperformed across the wider relevant industry. The companys shares have gained 54.02% over the past 6 months, with this year growth rate of 14.71%, compared to 16.40% for the industry. Other than that, the company has, however, increased its growth outlook for the 2021 fiscal year revenue. Growth estimates for the current quarter are 12.50% and 12.50% for the next quarter. Revenue growth from the last financial year stood is estimated to be -13.30%. 6 analysts offering their estimates for the company have set an average revenue estimate of $310k for the current quarter. 6 have an estimated revenue figure of $330k for the next quarter concluding in Sep 2021. Year-ago sales stood $360k and $496k respectively for this quarter and the next, and analysts expect sales will shrink by -13.90% for the current quarter and -33.50% for the next. If we evaluate the companys growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 23.70% over the past 5 years. 5 Stocks Under $10 That Are Poised to Take Off Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck. Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck. Add them to your watchlist before they take off! Get the Top 5 Stocks Now! Sponsored  INFI Dividends  Infinity Pharmaceuticals Inc. is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the companys debt issue. Infinity Pharmaceuticals Inc. (NASDAQ:INFI)s Major holders  Insiders own 2.17% of the company shares, while shares held by institutions stand at 53.67% with a share float percentage of 54.86%. Investors are also buoyed by the number of investors in a company, with Infinity Pharmaceuticals Inc. having a total of 98 institutions that hold shares in the company. The top two institutional holders are BVF Inc. with over 8.38 million shares worth more than $27.08 million. As of Mar 30, 2021, BVF Inc. held 9.46% of shares outstanding. The other major institutional holder is Consonance Capital Management LP, with the holding of over 6.58 million shares as of Mar 30, 2021. The firms total holdings are worth over $21.24 million and represent 7.42% of shares outstanding. Also the top two Mutual Funds that are holding companys shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Mar 30, 2021, the former fund manager holds about 2.32% shares in the company for having 2.06 million shares of worth $6.64 million while later fund manager owns 1.38 million shares of worth $4.45 million as of Mar 30, 2021, which makes it owner of about 1.55% of companys outstanding stock.